Trinity Biotech (TRIB) Other Non Operating Income (2009 - 2022)
Trinity Biotech (TRIB) posted quarterly Other Non Operating Income of -$197000.0 for Q1 2022, up 48.16% year-on-year from -$132966.3 in Q1 2021, and down 27.92% on a QoQ basis from -$154000.0 in Q4 2021.
Trinity Biotech (TRIB) Other Non Operating Income (2009 - 2022) Analysis & Trends
Trinity Biotech (TRIB) has reported Other Non Operating Income for 14 consecutive years, with -$197000.0 the latest figure, recorded in Q1 2022.
- Quarterly Other Non Operating Income rose 48.16% year-over-year to -$197000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was -$914000.0 (up 10.83% YoY) and the FY2021 annual result came in at -$1.1 million, down 40.51% from the prior year.
- Other Non Operating Income eased to -$197000.0 in Q1 2022 per TRIB's latest filing, from -$154000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for TRIB reached as high as -$123000.0 in Q4 2019 and fell as low as -$434000.0 in Q1 2018.
- A 5-year average of -$243529.4 and a median of -$213000.0 in 2020 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2019 — Other Non Operating Income jumped 59.45% — and 2021, when it sank 183.58%.
- Year by year, Other Non Operating Income stood at -$205000.0 in 2018, then jumped by 40.0% to -$123000.0 in 2019, then slumped by 124.39% to -$276000.0 in 2020, then jumped by 44.2% to -$154000.0 in 2021, then fell by 27.92% to -$197000.0 in 2022.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$197000.0, -$154000.0, and -$252000.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -197,000.00 |
| Dec 31, 2021 | -154,000.00 |
| Sep 30, 2021 | -252,000.00 |
| Jun 30, 2021 | -311,000.00 |
| Mar 31, 2021 | -380,000.00 |
| Dec 31, 2020 | -276,000.00 |
| Sep 30, 2020 | -156,000.00 |
| Jun 30, 2020 | -213,000.00 |
| Mar 31, 2020 | -134,000.00 |
| Dec 31, 2019 | -123,000.00 |
| Sep 30, 2019 | -252,000.00 |
| Jun 30, 2019 | -181,000.00 |
| Mar 31, 2019 | -176,000.00 |
| Dec 31, 2018 | -205,000.00 |
| Sep 30, 2018 | -367,000.00 |
| Jun 30, 2018 | -329,000.00 |
| Mar 31, 2018 | -434,000.00 |
| Dec 31, 2017 | -249,000.00 |
| Sep 30, 2017 | -265,000.00 |
| Jun 30, 2017 | -130,000.00 |